ESC 2024 | SCOFF Trial: Fasting or No Fasting before Cardiac Catheterization Procedures

Millions of people undergo either diagnostic or therapeutic coronary procedures that require sedation. The aim of this study was to assess whether food restriction is necessary before sedation in these procedures. 

This was a randomized study in centers of Australia. Patients were randomly assigned 1:1 to two groups: the fasting group (6 hours with no solid food and 2 without any liquids) and the no restriction group (habitual diet).

The primary outcome was a composite of events including aspiration pneumonia, hypotension, hyper and hypo glycaemia. 

716 patients were included, mean age 69, 35% women. Primary end point occurred in 19.1% of the fasting group and 12% of the regular diet group. Upon intention to treat analysis, the net difference was -5.2% in favor of the no fast group, confirming non inferiority for this strategy.

Read also: ESC 2024 | SENIOR RITA: Invasive Strategy for Elderly Patients with ACS.

As regards patient satisfaction, it was significantly higher in the no fast group (15±4.3 vs. 11±4.0 satisfaction).

This study, together with the CHOW-NOW, TONIC and Fast-CIED studies, shows there is solid evidence in favor of the lack of benefit of fasting prior these kind of procedures. 

Presented by David Ferreia at Hot-Line Sessions, ESC Congress 2024, August 30 thru September 2, London, England  


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

AHA 2024 | VANISH2 Trial

Cardiac defibrillator implants (CDIs) have been shown to improve survival in patients with ischemic cardiomyopathy and ventricular tachycardia (VT). However, approximately one third of...

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

AHA 2024 | VANISH2 Trial

Cardiac defibrillator implants (CDIs) have been shown to improve survival in patients with ischemic cardiomyopathy and ventricular tachycardia (VT). However, approximately one third of...

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...